Objectives
NAFLD, non-obese
OBESE
Therefore, we hypothesized that ICR would be effective in reducing liver fat content measured using magnetic resonance imaging-proton density fat fraction (MRI-PDFF) compared to SOC in patients with NAFLD. Finally, we developed a prospective, randomized controlled trial (RCT) to evaluate the effect of 12-week ICR on improving liver fat content in NAFLD, stratifying patients into obese and non-obese groups.